Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Clinical trial NCT04562558 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04562558
Sponsor: xiang yang
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Gestational Trophoblastic Tumor Gestational Trophoblastic Neoplasia Stage I Gestational Trophoblastic Tumor Stage II Gestational Trophoblastic Tumor Stage III Gestational Trophoblastic Tumor Invasive Mole Choriocarcinoma

Start date: 2020-09-29
Primary completion: 2024-11-11
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.